Monograph Details
|
|
Gastrointestinal Tract
> Nausea
|
|
TIGAN |
| Manufacturer |
|
King Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Trimethobenzamide HCl 300mg; caps. |
| Also |
|
• TIGAN INJECTION
|
| Indications |
|
Treatment of post-op or gastroenteritis-associated nausea and vomiting. |
| Children |
Not recommended.
|
| Adults |
|
300mg 3–4 times daily. |
| Contraindications |
|
Injection (children). |
| Precautions |
|
Acute febrile illness. Encephalitides. Dehydration. Electrolyte imbalance. Children (Reye's syndrome). Elderly. Debilitated. Pregnancy, nursing mothers: not recommended. |
| Interactions |
|
Potentiates alcohol, other CNS depressants. |
| Adverse Reactions |
|
Extrapyramidal reactions, may mask emetic signs of disease, drowsiness, blood dyscrasias, blurred vision, coma, seizures, depression, diarrhea, dizziness, jaundice, hypotension (inj), headache, muscle cramps, opisthotonos. |
| How Supplied |
Caps—100
Single-use vials (2mL)—25
Multi-dose vial (20mL)—1 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
